Michael Pham, M.D., M.P.H.

Cardiologist

Heart Transplant Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-5468
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Advanced Heart Failure and Transplant Cardiology, American Board of Internal Medicine

Internship: UCSF Medical Center (1999) CA

Medical Education: UCSF Medical Center (1998) CA

Residency: UCSF Medical Center (2001) CA

Fellowship: Stanford University School of Medicine (2002) CA

Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2004)

Administrative Appointments

Associate Medical Director, Heart Transplant Program, Stanford Hospital and Clinics (2011 - Present)

UNOS Primary Heart Transplant Physician, Stanford Hospital and Clinics (2011 - Present)

Medical Director, Advanced Heart Failure and Transplantation, VA Palo Alto Health Care System (2005 - Present)

Chair, Heart Transplant Quality Council, Stanford Hospital and Clinics (2010 - Present)

Co-Chair, Solid Organ Transplant Quality Council, Stanford Hospital and Clinics (2011 - Present)

Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients
Deng, M. C., Elashoff, B., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., & Valantine, H. A. (2014). Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients. TRANSPLANTATION, 97(6), 708-714.

B-Type Natriuretic Peptide Predicts 30-Day Readmission for Heart Failure but not Readmission for Other Causes.
Flint, K. M., Allen, L. A., Pham, M., & Heidenreich, P. A. (2014). B-Type Natriuretic Peptide Predicts 30-Day Readmission for Heart Failure but not Readmission for Other Causes. Journal of the American Heart Association, 3(3).

Granulocyte Colony-Stimulating Factor Therapy Is Associated With a Reduced Incidence of Acute Rejection Episodes or Allograft Vasculopathy in Heart Transplant Recipients
Vrtovec, B., Haddad, F., Pham, M., Deuse, T., Fearon, W. F., & Hunt, S. A. (2013). Granulocyte Colony-Stimulating Factor Therapy Is Associated With a Reduced Incidence of Acute Rejection Episodes or Allograft Vasculopathy in Heart Transplant Recipients. TRANSPLANTATION PROCEEDINGS, 45(6), 2406-2409.

Forecasting the impact of heart failure in the United States: a policy statement from the american heart association.
Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., & Trogdon, J. G. (2013). Forecasting the impact of heart failure in the United States: a policy statement from the american heart association. Circulation. Heart failure, 6(3), 606-619.

Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation
Sudini, N. L., Huo, J., Pan, S., Montoya, J., Leon, S., & Haddad, F. (2013). Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 32(4), S254-S254.

Divergent Trends in Survival and Readmission Following a Hospitalization for Heart Failure in the Veterans Affairs Health Care System 2002 to 2006
Heidenreich, P. A., Sahay, A., Kapoor, J. R., Pham, M. X., & Massie, B. (2010). Divergent Trends in Survival and Readmission Following a Hospitalization for Heart Failure in the Veterans Affairs Health Care System 2002 to 2006. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56(5), 362-368.

Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation
Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., & Valantine, H. A. (2010). Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 362(20), 1890-1900.

Changing trends in infectious disease in heart transplantation
Haddad, F., Deuse, T., Pham, M., Khazanie, P., Rosso, F., & Montoya, J. G. (2010). Changing trends in infectious disease in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(3), 306-315.

Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection
Haddad, F., Fisher, P., Pham, M., Berry, G., Weisshaar, D., & Hunt, S. (2009). Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(4), 312-319.

Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation
Khazanie, P., Haddad, F., Simos, A. M., Pham, M., Weisshaar, D. M., & Fearon, W. (2009). Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(10), A182-A182.

Microvascular Drysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation
Khazanie, P., Haddad, F., Simos, A. M., Weissbaar, D. M., Desai, S. V., & Fearon, W. (2009). Microvascular Drysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S228-S228.

Changing Trends in Infectious Complications among Heart Transplant Recipients
Haddad, F., Deuse, T., Rosso, P., Pham, M., Khazanie, P., & Montoya, J. G. (2009). Changing Trends in Infectious Complications among Heart Transplant Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S237-S238.

Twenty-year survivors of heart transplantation at Stanford University
Deuse, T., Haddad, F., Pham, M., Hunt, S., Valantine, H., & Reitz, B. A. (2008). Twenty-year survivors of heart transplantation at Stanford University. AMERICAN JOURNAL OF TRANSPLANTATION, 8(9), 1769-1774.

Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation
Sinha, S. S., Pham, M. X., Vagelos, R. H., Perlroth, M. G., Hunt, S. A., & Fearon, W. F. (2008). Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. AMERICAN HEART JOURNAL, 155(5).

Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial
Pham, M. X., Deng, M. C., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. (2007). Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(8), 808-814.

Molecular testing in the management of cardiac transplant recipients: Initial clinical experience
Starling, R. C., Pham, M., Valantine, H., Miller, L., Eisen, H., & Deng, M. C. (2006). Molecular testing in the management of cardiac transplant recipients: Initial clinical experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(12), 1389-1395.

Rapamycin therapy improves coronary physiology after cardiac transplantation
Sinha, S. S., Lee, D. P., Pham, M. X., Vagelos, R. H., Hunt, S. A., & Fearon, W. F. (2006). Rapamycin therapy improves coronary physiology after cardiac transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 47(4), 51A-51A.

Prognostic value electrocardiographic criteria for left ventricular hypertrophy
Hsieh, B. P., Pham, M. X., & Froelicher, V. F. (2005). Prognostic value electrocardiographic criteria for left ventricular hypertrophy. AMERICAN HEART JOURNAL, 150(1), 161-167.

Prognostic value of low-level cardiac troponin-1 elevations in patients without definite acute coronary syndromes
Pham, M. X., Whooley, M. A., Evans, G. T., Liu, C., Emadi, H., & Fleischmann, K. E. (2004). Prognostic value of low-level cardiac troponin-1 elevations in patients without definite acute coronary syndromes. AMERICAN HEART JOURNAL, 148(5), 776-782.

Cardiac xenotransplantation
Pham, M. X., Hunt, S. A., & Johnson, F. L. (2004). Cardiac xenotransplantation. CORONARY ARTERY DISEASE, 15(2), 99-105.